Literature DB >> 9322532

Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas.

L Vinter-Jensen1, C O Juhl, P S Teglbjaerg, S S Poulsen, E Z Dajani, E Nexø.   

Abstract

BACKGROUND & AIMS: Epidermal growth factor (EGF), transforming growth factor alpha (TGF-alpha), and the EGF receptor are often overexpressed in chronic pancreatitis and in malignant pancreatic growth. Transgenic mice overexpressing TGF-alpha develop tissue changes in the pancrease resembling changes found in chronic pancreatitis. The effects of systemic treatment with EGF on the porcine pancrease were investigated in this study.
METHODS: Mature Goettingen minipigs were treated with solvent (n = 5), EGF (30 micrograms.kg-1.day-1; n = 6) for 4 weeks, or EGF (30 micrograms.kg-1.day-1; n = 5) for 5 weeks followed by 3 weeks of recovery. Pancreata were studied by routine histological examination and electron microscopy and were immunostained for proliferating cell nuclear antigen (PCNA).
RESULTS: In the EGF-treated animals, mainly larger interlobular ducts of the pancreas appeared to be considerably hyperplastic, with an increased number of nuclei that stained for PCNA. The epithelia of these ducts were increased in height, with accumulations of glycoconjugates in the columnar cells and in an increased number of goblet cells.
CONCLUSIONS: A new approach to experimentally induced hyperplastic changes of the excretory ducts of the pancreas is presented. Because ductal changes with glycoconjugate accumulations are common features of chronic pancreatitis and pancreatic cancer, the findings may be relevant to the pathogeneses of these conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9322532     DOI: 10.1053/gast.1997.v113.pm9322532

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Epidermal growth factor receptor, somatostatin and bcl-2 in human pancreatic tumor xenografts. An immunohistochemical study.

Authors:  A Zalatnai
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

2.  Overexpression of caspase-1 in pancreatic disorders: implications for a function besides apoptosis.

Authors:  M Ramadani; F Gansauge; S Schlosser; Y Yang; H G Beger; S Gansauge
Journal:  J Gastrointest Surg       Date:  2001 Jul-Aug       Impact factor: 3.452

3.  Pancreatic expression of keratinocyte growth factor leads to differentiation of islet hepatocytes and proliferation of duct cells.

Authors:  M L Krakowski; M R Kritzik; E M Jones; T Krahl; J Lee; M Arnush; D Gu; N Sarvetnick
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

4.  Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation.

Authors:  E Hakonen; J Ustinov; I Mathijs; J Palgi; L Bouwens; P J Miettinen; T Otonkoski
Journal:  Diabetologia       Date:  2011-04-21       Impact factor: 10.122

5.  Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes.

Authors:  Stephen Hanley
Journal:  Mcgill J Med       Date:  2009-11-16

Review 6.  Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications.

Authors:  Jorge Berlanga-Acosta; Jorge Gavilondo-Cowley; Pedro López-Saura; Tania González-López; María D Castro-Santana; Ernesto López-Mola; Gerardo Guillén-Nieto; Luis Herrera-Martinez
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

7.  Central role of the EGF receptor in neurometabolic aging.

Authors:  Sana Siddiqui; Meng Fang; Bin Ni; Daoyuan Lu; Bronwen Martin; Stuart Maudsley
Journal:  Int J Endocrinol       Date:  2012-06-17       Impact factor: 3.257

8.  Purified human pancreatic duct cell culture conditions defined by serum-free high-content growth factor screening.

Authors:  Corinne A Hoesli; James D Johnson; James M Piret
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

9.  EGFR signaling promotes β-cell proliferation and survivin expression during pregnancy.

Authors:  Elina Hakonen; Jarkko Ustinov; Jaan Palgi; Päivi J Miettinen; Timo Otonkoski
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

10.  The combined effect of PDX1, epidermal growth factor and poly-L-ornithine on human amnion epithelial cells' differentiation.

Authors:  Shruti Balaji; Yu Zhou; Anasuya Ganguly; Emmanuel C Opara; Shay Soker
Journal:  BMC Dev Biol       Date:  2016-04-12       Impact factor: 1.978

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.